# Rivastigmine

## Exelon patch 5

| 藥物代碼           | EEXEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Mild to moderate Alzheimer's disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 副作用             | More frequent: diarrhea; weight loss; Iindigestion; loss of strength ; nausea; vomiting; loss of appetite; abdominal pain; confusion; constipation; depression; dizziness; fatigue ; headache; insomniaLess frequent: high blood pressure; fainting; general feeling of discomfort or illness; increased sweating; runny nose.Rare: aggression; seizures; trembling and shaking of hands and fingers; trouble in urinating                                                                       |
| 禁忌               | hypersensitivity to rivastigmine, other carbamate derivatives or any other components of the product.                                                                                                                                                                                                                                                                                                                                                                                            |
| 藥物保存方式       | 室溫 (< 30℃)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量           | Mild-to-moderate Alzheimer’s dementia: 1.Initial, one patch QD, topically 2.Conversion from oral therapy: If oral daily dose <6 mg, switch to 4.6 mg/24 hours patch. Apply patch on the next day following last oral dose. * if oral daily dose 6-12 mg, switch to 9.5 mg/24 hours patch(patch 10).但目前國內沒有patch 10劑型. Dosage adjustment in renal impairment : No data, but oral form is not required. Dosage adjustment in hepatic impairment : No data, but oral form is not required. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注射劑給藥建議途徑 | EXT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

